These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | ||||
|
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | ||||
|
|
|
||||
| (State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.) | ||||
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||||||||||
|
|
|
|
||||||||||||
|
|
þ | No | o | |||||||||||
|
|
þ | No | o | |||||||||||
|
|
þ | Accelerated filer | o | |||||||||||
| Non-accelerated filer | o | Smaller reporting company |
|
|||||||||||
| Emerging growth company |
|
|||||||||||||
| o | ||||||||
| Yes | o | No |
|
|||||||||||
|
PART I - FINANCIAL INFORMATION
(Unaudited)
|
Page | |||||||
| Item 5. | ||||||||
| (In millions, except shares and per share data) |
Three Months Ended
June 30, |
Six Months Ended
June 30, |
|||||||||||||||||||||
| 2025 | 2024 | 2025 | 2024 | ||||||||||||||||||||
| Net sales | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| Cost of sales |
|
|
|
|
|||||||||||||||||||
| Gross profit |
|
|
|
|
|||||||||||||||||||
| Selling and administrative expense |
|
|
|
|
|||||||||||||||||||
| Research and development expense |
|
|
|
|
|||||||||||||||||||
| Operating income |
|
|
|
|
|||||||||||||||||||
| Interest expense, net |
(
|
(
|
(
|
(
|
|||||||||||||||||||
| Net foreign currency transaction (loss) gain |
(
|
|
(
|
|
|||||||||||||||||||
| Other (expense) income, net |
(
|
|
(
|
|
|||||||||||||||||||
| Income before income taxes |
|
|
|
|
|||||||||||||||||||
| Income tax expense |
|
|
|
|
|||||||||||||||||||
| Net income | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| Net income per share | |||||||||||||||||||||||
| Basic | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| Diluted | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| Weighted average shares outstanding | |||||||||||||||||||||||
| Basic |
|
|
|
|
|||||||||||||||||||
| Diluted |
|
|
|
|
|||||||||||||||||||
| (In millions) |
Three Months Ended
June 30, |
Six Months Ended
June 30, |
|||||||||||||||||||||
| 2025 | 2024 | 2025 | 2024 | ||||||||||||||||||||
| Net income | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| Other comprehensive income (loss): | |||||||||||||||||||||||
|
Foreign currency translation adjustments (net of related tax benefit (expense) of $
|
|
(
|
|
(
|
|||||||||||||||||||
|
Pension and postretirement medical benefits (net of related tax expense of $
|
|
|
|
|
|||||||||||||||||||
|
Derivative financial instruments (net of related tax benefit of $
|
(
|
|
(
|
|
|||||||||||||||||||
| Total other comprehensive income (loss), net of tax |
|
(
|
|
(
|
|||||||||||||||||||
| Total comprehensive income including noncontrolling interest |
|
|
|
|
|||||||||||||||||||
| Foreign currency translation adjustments attributable to noncontrolling interest |
|
|
|
|
|||||||||||||||||||
| Comprehensive income attributable to Tennant Company | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| (Unaudited) | |||||||||||
| (In millions, except shares and per share data) |
June 30,
2025 |
December 31,
2024 |
|||||||||
| ASSETS | |||||||||||
| Cash and cash equivalents | $ |
|
$ |
|
|||||||
|
Receivables, less allowances of $
|
|
|
|||||||||
| Inventories |
|
|
|||||||||
| Prepaid and other current assets |
|
|
|||||||||
| Total current assets |
|
|
|||||||||
|
Property, plant and equipment, less accumulated depreciation of $
|
|
|
|||||||||
| Operating lease assets |
|
|
|||||||||
| Goodwill |
|
|
|||||||||
| Intangible assets, net |
|
|
|||||||||
| Other assets |
|
|
|||||||||
| Total assets | $ |
|
$ |
|
|||||||
| LIABILITIES AND EQUITY | |||||||||||
| Current portion of long-term debt | $ |
|
$ |
|
|||||||
| Accounts payable |
|
|
|||||||||
| Employee compensation and benefits |
|
|
|||||||||
| Other current liabilities |
|
|
|||||||||
| Total current liabilities |
|
|
|||||||||
| Long-term debt |
|
|
|||||||||
| Long-term operating lease liabilities |
|
|
|||||||||
| Employee benefits |
|
|
|||||||||
| Deferred income taxes |
|
|
|||||||||
| Other liabilities |
|
|
|||||||||
| Total long-term liabilities |
|
|
|||||||||
| Total liabilities | $ |
|
$ |
|
|||||||
| Commitments and contingencies (Note 12) |
|
|
|||||||||
|
Common Stock, $
|
|
|
|||||||||
| Additional paid-in capital |
|
|
|||||||||
| Retained earnings |
|
|
|||||||||
| Accumulated other comprehensive loss |
(
|
(
|
|||||||||
| Total Tennant Company shareholders' equity |
|
|
|||||||||
| Noncontrolling interest |
|
|
|||||||||
| Total equity |
|
|
|||||||||
| Total liabilities and total equity | $ |
|
$ |
|
|||||||
| (In millions) |
Six Months Ended
June 30, |
||||||||||
| 2025 | 2024 | ||||||||||
| OPERATING ACTIVITIES | |||||||||||
| Net income | $ |
|
$ |
|
|||||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||||||||
| Depreciation expense |
|
|
|||||||||
| Amortization expense |
|
|
|||||||||
| Deferred income tax benefit |
(
|
(
|
|||||||||
| Share-based compensation expense |
|
|
|||||||||
| Bad debt and returns expense |
|
|
|||||||||
| Other, net |
|
|
|||||||||
| Changes in operating assets and liabilities: | |||||||||||
| Receivables |
(
|
(
|
|||||||||
| Inventories |
(
|
(
|
|||||||||
| Accounts payable |
(
|
|
|||||||||
| Employee compensation and benefits |
(
|
(
|
|||||||||
| Other assets and liabilities |
(
|
(
|
|||||||||
| Net cash provided by operating activities |
|
|
|||||||||
| INVESTING ACTIVITIES | |||||||||||
| Purchases of property, plant and equipment |
(
|
(
|
|||||||||
| Purchase of investment |
|
(
|
|||||||||
| Payments made in connection with business acquisition, net of cash acquired |
|
(
|
|||||||||
| Investment in leased assets |
(
|
(
|
|||||||||
| Cash received from leased assets |
|
|
|||||||||
| Net cash used in investing activities |
(
|
(
|
|||||||||
| FINANCING ACTIVITIES | |||||||||||
| Proceeds from borrowings |
|
|
|||||||||
| Repayments of borrowings |
(
|
(
|
|||||||||
|
(Repurchases) proceeds from exercise of stock options, net of employee tax withholdings obligations of $
|
(
|
|
|||||||||
| Repurchases of common stock |
(
|
(
|
|||||||||
| Dividends paid |
(
|
(
|
|||||||||
| Net cash (used in) provided by financing activities |
(
|
|
|||||||||
| Effect of exchange rate changes on cash and cash equivalents |
|
(
|
|||||||||
| Net decrease in cash and cash equivalents |
(
|
(
|
|||||||||
| Cash and cash equivalents at beginning of period |
|
|
|||||||||
| Cash and cash equivalents at end of period | $ |
|
$ |
|
|||||||
|
SUPPLEMENTAL CASH FLOW INFORMATION
|
Six Months Ended
June 30, |
||||||||||
| (In millions) | 2025 | 2024 | |||||||||
| Cash paid for income taxes | $ |
|
$ |
|
|||||||
| Cash paid for interest |
|
|
|||||||||
| Cash paid for amounts included in the measurement of lease liabilities: | |||||||||||
| Operating cash flows from operating leases |
|
|
|||||||||
| Financing cash flows from financing leases |
|
|
|||||||||
| Lease assets obtained in exchange for new operating lease liabilities |
|
|
|||||||||
| Lease assets obtained in exchange for new financing lease liabilities |
|
|
|||||||||
| Supplemental non-cash investing and financing activities: | |||||||||||
| Capital expenditures in accounts payable |
|
|
|||||||||
| Tennant Company Shareholders | |||||||||||||||||||||||||||||||||||||||||||||||
|
Common
Shares |
Common
Stock |
Additional
Paid-in Capital |
Retained
Earnings |
Accumulated
Other Comprehensive Loss |
Tennant
Company Shareholders' Equity |
Noncontrolling
Interest |
Total Equity | ||||||||||||||||||||||||||||||||||||||||
|
Balance, December 31, 2024
|
|
$ |
|
$ |
|
$ |
|
$ |
(
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||||||||||||||||
| Net income | — | — |
|
— |
|
— |
|
||||||||||||||||||||||||||||||||||||||||
| Other comprehensive income | — | — | — |
|
|
— |
|
||||||||||||||||||||||||||||||||||||||||
|
Issue stock for directors, employee benefit and stock plans, net of related tax withholdings of
|
|
(
|
(
|
— | — |
(
|
— |
(
|
|||||||||||||||||||||||||||||||||||||||
| Share-based compensation | — |
|
— | — |
|
— |
|
||||||||||||||||||||||||||||||||||||||||
| Repurchases of common stock |
(
|
— |
(
|
— | — |
(
|
— |
(
|
|||||||||||||||||||||||||||||||||||||||
|
Dividends paid $
|
— | — |
(
|
— |
(
|
— |
(
|
||||||||||||||||||||||||||||||||||||||||
| Other | — | — | — | — | — |
|
|
||||||||||||||||||||||||||||||||||||||||
| Balance, March 31, 2025 |
|
$ |
|
$ |
|
$ |
|
$ |
(
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||||||||||||||||
| Net income | — | — |
|
— |
|
— |
|
||||||||||||||||||||||||||||||||||||||||
| Other comprehensive income | — | — | — |
|
|
— |
|
||||||||||||||||||||||||||||||||||||||||
|
Issue stock for directors, employee benefit and stock plans, net of related tax withholdings of
|
|
— |
(
|
— | — |
(
|
— |
(
|
|||||||||||||||||||||||||||||||||||||||
| Share-based compensation | — |
|
— | — |
|
— |
|
||||||||||||||||||||||||||||||||||||||||
| Repurchases of common stock |
(
|
— |
(
|
— | — |
(
|
— |
(
|
|||||||||||||||||||||||||||||||||||||||
|
Dividends paid $
|
— | — |
(
|
— |
(
|
— |
(
|
||||||||||||||||||||||||||||||||||||||||
| Other | — | — | — | — | — |
|
|
||||||||||||||||||||||||||||||||||||||||
| Balance, June 30, 2025 |
|
$ |
|
$ |
|
$ |
|
$ |
(
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||||||||||||||||
| Tennant Company Shareholders | |||||||||||||||||||||||||||||||||||||||||||||||
|
Common
Shares |
Common
Stock |
Additional
Paid-in Capital |
Retained
Earnings |
Accumulated
Other Comprehensive Loss |
Tennant
Company Shareholders' Equity |
Noncontrolling
Interest |
Total Equity | ||||||||||||||||||||||||||||||||||||||||
| Balance, December 31, 2023 |
|
$ |
|
$ |
|
$ |
|
$ |
(
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||||||||||||||||
| Net income | — | — |
|
— |
|
— |
|
||||||||||||||||||||||||||||||||||||||||
| Other comprehensive income | — | — | — |
(
|
(
|
— |
(
|
||||||||||||||||||||||||||||||||||||||||
|
Issue stock for directors, employee benefit and stock plans, net of related tax withholdings of
|
|
|
|
— | — |
|
— |
|
|||||||||||||||||||||||||||||||||||||||
| Share-based compensation | — |
|
— | — |
|
— |
|
||||||||||||||||||||||||||||||||||||||||
| Repurchases of common stock |
(
|
— |
(
|
— | — |
(
|
— |
(
|
|||||||||||||||||||||||||||||||||||||||
|
Dividends paid $
|
— | — |
(
|
— |
(
|
— |
(
|
||||||||||||||||||||||||||||||||||||||||
| Balance, March 31, 2024 |
|
$ |
|
$ |
|
$ |
|
$ |
(
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||||||||||||||||
| Net income | — | — |
|
— |
|
— |
|
||||||||||||||||||||||||||||||||||||||||
| Other comprehensive income | — | — | — |
(
|
(
|
— |
(
|
||||||||||||||||||||||||||||||||||||||||
|
Issue stock for directors, employee benefit and stock plans, net of related tax withholdings and repurchases of
|
|
— |
|
— | — |
|
— |
|
|||||||||||||||||||||||||||||||||||||||
| Share-based compensation | — |
|
— | — |
|
— |
|
||||||||||||||||||||||||||||||||||||||||
| Repurchases of common stock |
(
|
— |
(
|
— | — |
(
|
— |
(
|
|||||||||||||||||||||||||||||||||||||||
|
Dividends paid $
|
— | — |
(
|
— |
(
|
— |
(
|
||||||||||||||||||||||||||||||||||||||||
| Balance, June 30, 2024 |
|
$ |
|
$ |
|
$ |
|
$ |
(
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||||||||||||||||
|
Three Months Ended
June 30, |
Six Months Ended
June 30, |
||||||||||||||||||||||
| 2025 | 2024 | 2025 | 2024 | ||||||||||||||||||||
| Americas | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| Europe, Middle East and Africa |
|
|
|
|
|||||||||||||||||||
| Asia Pacific |
|
|
|
|
|||||||||||||||||||
| Total | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
|
Three Months Ended
June 30, |
Six Months Ended
June 30, |
||||||||||||||||||||||
| 2025 | 2024 | 2025 | 2024 | ||||||||||||||||||||
| Equipment | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| Parts and consumables |
|
|
|
|
|||||||||||||||||||
| Service and other |
|
|
|
|
|||||||||||||||||||
| Total | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
|
Three Months Ended
June 30, |
Six Months Ended
June 30, |
||||||||||||||||||||||
| 2025 | 2024 | 2025 | 2024 | ||||||||||||||||||||
| Sales direct to consumer | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| Sales to distributors |
|
|
|
|
|||||||||||||||||||
| Total | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
|
Six Months Ended
June 30, |
|||||||||||
| 2025 | 2024 | ||||||||||
| Beginning balance | $ |
|
$ |
|
|||||||
| Additions to sales incentive accrual |
|
|
|||||||||
| Contract payments |
(
|
(
|
|||||||||
| Foreign currency fluctuations |
|
(
|
|||||||||
| Ending balance | $ |
|
$ |
|
|||||||
|
Six Months Ended
June 30, |
|||||||||||
| 2025 | 2024 | ||||||||||
| Beginning balance | $ |
|
$ |
|
|||||||
| Increase in deferred revenue representing our obligation to satisfy future performance obligations |
|
|
|||||||||
| Decrease in deferred revenue for amounts recognized in net sales for satisfied performance obligations |
(
|
(
|
|||||||||
| Foreign currency fluctuations |
|
(
|
|||||||||
| Ending balance | $ |
|
$ |
|
|||||||
|
Remaining 2025
|
$ |
|
|||
| 2026 |
|
||||
| 2027 |
|
||||
| 2028 |
|
||||
| 2029 |
|
||||
| Thereafter |
|
||||
| Total | $ |
|
|||
|
Three Months Ended
June 30, |
Six Months Ended
June 30, |
||||||||||||||||||||||
| 2025 | 2024 | 2025 | 2024 | ||||||||||||||||||||
| Severance-related costs | $ |
(
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| Total pre-tax restructuring costs | $ |
(
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
|
Six Months Ended
June 30, |
|||||||||||
| 2025 | 2024 | ||||||||||
| Beginning balance | $ |
|
$ |
|
|||||||
| New charges |
|
|
|||||||||
| Cash payments |
(
|
(
|
|||||||||
| Foreign currency fluctuations |
|
(
|
|||||||||
| Adjustments to accrual |
(
|
(
|
|||||||||
| Ending balance | $ |
|
$ |
|
|||||||
|
June 30,
2025 |
December 31,
2024 |
||||||||||
| Inventories carried at LIFO: | |||||||||||
|
Finished goods
(a)
|
$ |
|
$ |
|
|||||||
| Raw materials and work-in-process |
|
|
|||||||||
|
Excess of FIFO over LIFO cost
(b)
|
(
|
(
|
|||||||||
| Total LIFO inventories | $ |
|
$ |
|
|||||||
| Inventories carried at FIFO: | |||||||||||
|
Finished goods
(a)
|
$ |
|
$ |
|
|||||||
| Raw materials and work-in-process |
|
|
|||||||||
| Total FIFO inventories | $ |
|
$ |
|
|||||||
| Total inventories | $ |
|
$ |
|
|||||||
| Goodwill |
Accumulated
Impairment
Losses
|
Total | |||||||||||||||
|
Balance as of December 31, 2024
|
$ |
|
$ |
(
|
$ |
|
|||||||||||
| Foreign currency fluctuations |
|
(
|
|
||||||||||||||
|
Balance as of June 30, 2025
|
$ |
|
$ |
(
|
$ |
|
|||||||||||
| Customer Lists | Trade Names | Technology | Total | ||||||||||||||||||||
|
Balance as of June 30, 2025
|
|||||||||||||||||||||||
| Original cost | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| Accumulated amortization |
(
|
(
|
(
|
(
|
|||||||||||||||||||
| Carrying value | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| Weighted average original life (in years) |
|
|
|
||||||||||||||||||||
|
Balance as of December 31, 2024
|
|||||||||||||||||||||||
| Original cost | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| Accumulated amortization |
(
|
(
|
(
|
(
|
|||||||||||||||||||
| Carrying value | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| Weighted average original life (in years) |
|
|
|
||||||||||||||||||||
|
Remaining 2025
|
$ |
|
|||
| 2026 |
|
||||
| 2027 |
|
||||
| 2028 |
|
||||
| 2029 |
|
||||
| Thereafter |
|
||||
| Total | $ |
|
|||
| June 30, 2025 | December 31, 2024 | ||||||||||
| Credit facility borrowings: | |||||||||||
| Revolving credit facility borrowings | $ |
|
$ |
|
|||||||
| Finance lease liabilities |
|
|
|||||||||
| Bank overdrafts |
|
|
|||||||||
| Total debt |
|
|
|||||||||
|
Less: current portion of long-term debt
(a)
|
(
|
(
|
|||||||||
| Long-term debt | $ |
|
$ |
|
|||||||
|
Six Months Ended
June 30, |
|||||||||||
| 2025 | 2024 | ||||||||||
| Beginning balance | $ |
|
$ |
|
|||||||
| Additions charged to expense |
|
|
|||||||||
| Foreign currency fluctuations |
|
(
|
|||||||||
| Claims paid |
(
|
(
|
|||||||||
| Ending balance | $ |
|
$ |
|
|||||||
| Derivative Assets | Derivative Liabilities | ||||||||||||||||||||||||||||||||||
| Balance Sheet Location | June 30, 2025 | December 31, 2024 | Balance Sheet Location | June 30, 2025 | December 31, 2024 | ||||||||||||||||||||||||||||||
| Derivatives designated as cash flow hedges: | |||||||||||||||||||||||||||||||||||
| Interest rate swaps | Other current assets | $ |
|
$ |
|
Other current liabilities | $ |
|
$ |
|
|||||||||||||||||||||||||
| Interest rate swaps | Other assets |
|
|
Other liabilities |
|
|
|||||||||||||||||||||||||||||
| Derivatives designated as fair value hedges: | |||||||||||||||||||||||||||||||||||
| Cross-currency swaps | Other current assets |
|
|
Other current liabilities |
|
|
|||||||||||||||||||||||||||||
| Cross-currency swaps | Other assets |
|
|
Other liabilities |
|
|
|||||||||||||||||||||||||||||
| Derivatives designated as net investment hedges: | |||||||||||||||||||||||||||||||||||
| Cross-currency swaps | Other current assets |
|
|
Other current liabilities |
|
|
|||||||||||||||||||||||||||||
| Cross-currency swaps | Other assets |
|
|
Other liabilities |
|
|
|||||||||||||||||||||||||||||
| Derivatives not designated as hedging instruments: | |||||||||||||||||||||||||||||||||||
|
Foreign currency forward contracts
(a)
|
Other current assets | $ |
|
$ |
|
Other current liabilities | $ |
|
$ |
|
|||||||||||||||||||||||||
|
Three Months Ended
June 30, |
|||||||||||||||||||||||
| 2025 | 2024 | ||||||||||||||||||||||
| Total | Gain (Loss) on Hedging | Total | Gain on Hedging | ||||||||||||||||||||
| Derivatives designated as cash flow hedges: | |||||||||||||||||||||||
| Interest expense, net | $ |
(
|
$ |
|
$ |
(
|
$ |
|
|||||||||||||||
| Net foreign currency transaction (loss) gain |
(
|
|
|
|
|||||||||||||||||||
| Derivatives designated as fair value hedges: | |||||||||||||||||||||||
| Interest expense, net |
(
|
|
(
|
|
|||||||||||||||||||
| Net foreign currency transaction (loss) gain |
(
|
(
|
|
|
|||||||||||||||||||
| Derivatives designated as net investment hedges: | |||||||||||||||||||||||
| Interest expense, net | $ |
(
|
$ |
|
$ |
(
|
$ |
|
|||||||||||||||
| Six Months Ended June 30, | |||||||||||||||||||||||
| 2025 | 2024 | ||||||||||||||||||||||
| Total | Gain (Loss) on Hedging | Total | Gain on Hedging | ||||||||||||||||||||
| Derivatives designated as cash flow hedges: | |||||||||||||||||||||||
| Interest expense, net | $ |
(
|
$ |
|
$ |
(
|
$ |
|
|||||||||||||||
| Net foreign currency transaction (loss) gain |
(
|
|
|
|
|||||||||||||||||||
| Derivatives designated as fair value hedges: | |||||||||||||||||||||||
| Interest expense, net |
(
|
|
(
|
|
|||||||||||||||||||
| Net foreign currency transaction (loss) gain |
(
|
(
|
|
|
|||||||||||||||||||
| Derivatives designated as net investment hedges: | |||||||||||||||||||||||
| Interest expense, net | $ |
(
|
$ |
|
$ |
(
|
$ |
|
|||||||||||||||
|
Three Months Ended
June 30, |
Six Months Ended
June 30, |
||||||||||||||||||||||
| 2025 | 2024 | 2025 | 2024 | ||||||||||||||||||||
| Derivatives designated as cash flow hedges: | |||||||||||||||||||||||
|
Net gain (loss) recognized in other comprehensive income (loss), net of tax
(a)
|
$ |
|
$ |
|
$ |
(
|
$ |
|
|||||||||||||||
| Net gain reclassified from accumulated other comprehensive income (loss) into income, net of tax, effective portion to interest expense, net |
|
|
|
|
|||||||||||||||||||
| Derivatives designated as fair value hedges: | |||||||||||||||||||||||
|
Net (loss) gain recognized in other comprehensive income (loss), net of tax
(a)
|
(
|
|
(
|
|
|||||||||||||||||||
| Net (loss) gain reclassified from accumulated other comprehensive income (loss) into income, net of tax, effective portion to interest expense, net |
(
|
|
(
|
|
|||||||||||||||||||
| Derivatives designated as net investment hedges: | |||||||||||||||||||||||
|
Net (loss) gain recognized in other comprehensive income (loss), net of tax
(a)
|
(
|
|
(
|
|
|||||||||||||||||||
| Net gain reclassified from accumulated other comprehensive (loss) income into income, net of tax, ineffective portion to interest expense, net |
|
|
|
|
|||||||||||||||||||
| Derivatives not designated as hedging instruments: | |||||||||||||||||||||||
|
Net (loss) gain recognized in income
(b)
|
$ |
(
|
$ |
|
$ |
(
|
$ |
|
|||||||||||||||
| Cost | Fair Value | Gross Unrealized Gains | Gross Unrealized Losses | ||||||||||||||||||||
|
Balance as of June 30, 2025
|
|||||||||||||||||||||||
| Available-for-sale debt securities | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| Equity securities |
|
|
— | — | |||||||||||||||||||
| Total debt and equity securities | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
|
Balance as of December 31, 2024
|
|||||||||||||||||||||||
| Available-for-sale debt securities | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| Equity securities |
|
|
— | — | |||||||||||||||||||
| Total debt and equity securities | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| Cost | Fair Value | |||||||
| After 5 years through 10 years | $ |
|
$ |
|
||||
| Total debt securities | $ |
|
$ |
|
||||
|
Fair
Value |
Level 1 | Level 2 | Level 3 | ||||||||||||||||||||
| Assets: | |||||||||||||||||||||||
| Equity securities | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| Debt securities |
|
|
|
|
|||||||||||||||||||
| Foreign currency forward contracts |
|
|
|
|
|||||||||||||||||||
| Cross-currency swaps |
|
|
|
|
|||||||||||||||||||
| Total assets |
|
|
|
|
|||||||||||||||||||
| Liabilities: | |||||||||||||||||||||||
| Foreign currency forward contracts |
|
|
|
|
|||||||||||||||||||
| Cross-currency swaps |
|
|
|
|
|||||||||||||||||||
| Interest rate swaps |
|
|
|
|
|||||||||||||||||||
| Total liabilities | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
|
Fair
Value |
Level 1 | Level 2 | Level 3 | ||||||||||||||||||||
| Assets: | |||||||||||||||||||||||
| Equity securities | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| Debt securities |
|
|
|
|
|||||||||||||||||||
| Foreign currency forward contracts |
|
|
|
|
|||||||||||||||||||
| Cross-currency swaps |
|
|
|
|
|||||||||||||||||||
| Interest rate swaps |
|
|
|
|
|||||||||||||||||||
| Total assets |
|
|
|
|
|||||||||||||||||||
| Liabilities: | |||||||||||||||||||||||
| Interest rate swaps |
|
|
|
|
|||||||||||||||||||
| Total liabilities | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| Six Months Ended June 30, 2025 | |||||||||||||||||||||||||||||
|
Foreign Currency
Translation
Adjustments
(1)
|
Pension and Post-
Retirement Medical Benefits |
Derivative Financial Instruments | Unrealized Gain on Debt Securities | Total | |||||||||||||||||||||||||
| Beginning balance | $ |
(
|
$ |
|
$ |
(
|
$ |
|
$ |
(
|
|||||||||||||||||||
| Other comprehensive income (loss) before reclassifications |
|
|
(
|
|
|
||||||||||||||||||||||||
| Amounts reclassified from accumulated other comprehensive loss |
(
|
|
|
|
(
|
||||||||||||||||||||||||
| Net current period other comprehensive income (loss) |
|
|
(
|
|
|
||||||||||||||||||||||||
| Ending balance | $ |
(
|
$ |
|
$ |
(
|
$ |
|
$ |
(
|
|||||||||||||||||||
| Six Months Ended June 30, 2024 | |||||||||||||||||||||||
|
Foreign Currency
Translation Adjustments |
Pension and Post-
Retirement Medical Benefits |
Derivative Financial Instruments | Total | ||||||||||||||||||||
| Beginning balance | $ |
(
|
$ |
|
$ |
(
|
$ |
(
|
|||||||||||||||
| Other comprehensive (loss) income before reclassifications |
(
|
|
|
(
|
|||||||||||||||||||
| Amounts reclassified from accumulated other comprehensive loss |
(
|
|
(
|
(
|
|||||||||||||||||||
| Net current period other comprehensive (loss) income |
(
|
|
|
(
|
|||||||||||||||||||
| Ending balance | $ |
(
|
$ |
|
$ |
|
$ |
(
|
|||||||||||||||
|
Three Months Ended
June 30, |
Six Months Ended
June 30, |
||||||||||||||||||||||
| 2025 | 2024 | 2025 | 2024 | ||||||||||||||||||||
| Numerator: | |||||||||||||||||||||||
| Net income | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| Denominator: | |||||||||||||||||||||||
| Basic - weighted average shares outstanding |
|
|
|
|
|||||||||||||||||||
| Effect of dilutive securities |
|
|
|
|
|||||||||||||||||||
| Diluted - weighted average shares outstanding |
|
|
|
|
|||||||||||||||||||
| Basic earnings per share | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| Diluted earnings per share | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
|
Three Months Ended
June 30, |
Six Months Ended
June 30, |
||||||||||||||||||||||||||||||||||||||||||||||
| 2025 | % | 2024 | % | 2025 | % | 2024 | % | ||||||||||||||||||||||||||||||||||||||||
| Net sales | $ | 318.6 | 100.0 | $ | 331.0 | 100.0 | $ | 608.6 | 100.0 | $ | 642.0 | 100.0 | |||||||||||||||||||||||||||||||||||
| Cost of sales | 184.5 | 57.9 | 188.3 | 56.9 | 354.5 | 58.2 | 361.8 | 56.4 | |||||||||||||||||||||||||||||||||||||||
| Gross profit | 134.1 | 42.1 | 142.7 | 43.1 | 254.1 | 41.8 | 280.2 | 43.6 | |||||||||||||||||||||||||||||||||||||||
| Selling and administrative expense | 93.7 | 29.4 | 92.9 | 28.1 | 184.4 | 30.3 | 182.8 | 28.5 | |||||||||||||||||||||||||||||||||||||||
| Research and development expense | 9.8 | 3.1 | 11.2 | 3.4 | 19.5 | 3.2 | 21.3 | 3.3 | |||||||||||||||||||||||||||||||||||||||
| Operating income | 30.6 | 9.6 | 38.6 | 11.7 | 50.2 | 8.2 | 76.1 | 11.9 | |||||||||||||||||||||||||||||||||||||||
| Interest expense, net | (2.2) | (0.7) | (2.5) | (0.8) | (4.5) | (0.7) | (4.8) | (0.7) | |||||||||||||||||||||||||||||||||||||||
| Net foreign currency transaction (loss) gain | (0.8) | (0.3) | 0.7 | 0.2 | (1.0) | (0.2) | 0.5 | 0.1 | |||||||||||||||||||||||||||||||||||||||
| Other (expense) income, net | (0.3) | (0.1) | 0.1 | — | (0.2) | — | 0.2 | — | |||||||||||||||||||||||||||||||||||||||
| Income before income taxes | 27.3 | 8.6 | 36.9 | 11.1 | 44.5 | 7.3 | 72.0 | 11.2 | |||||||||||||||||||||||||||||||||||||||
| Income tax expense | 7.1 | 2.2 | 9.0 | 2.7 | 11.2 | 1.8 | 15.7 | 2.4 | |||||||||||||||||||||||||||||||||||||||
| Net income | $ | 20.2 | 6.3 | $ | 27.9 | 8.4 | $ | 33.3 | 5.5 | $ | 56.3 | 8.8 | |||||||||||||||||||||||||||||||||||
| Net income per share - diluted | $ | 1.08 | $ | 1.45 | $ | 1.77 | $ | 2.94 | |||||||||||||||||||||||||||||||||||||||
| Three Months Ended June 30, | Six Months Ended June 30, | ||||||||||
| 2025 vs. 2024 | |||||||||||
| Price | 1.8% | 0.9% | |||||||||
| Volume | (6.3)% | (5.6)% | |||||||||
| Organic decline | (4.5)% | (4.7)% | |||||||||
| Acquisitions | —% | 0.2% | |||||||||
| Foreign currency | 0.8% | (0.7)% | |||||||||
| Total | (3.7)% | (5.2)% | |||||||||
|
Three Months Ended
June 30, |
Six Months Ended
June 30, |
||||||||||||||||||||||||||||||||||
| 2025 | 2024 | % Change | 2025 | 2024 | % Change | ||||||||||||||||||||||||||||||
| Americas | $ | 213.5 | $ | 227.8 | (6.3) | % | $ | 410.8 | $ | 443.4 | (7.4) | % | |||||||||||||||||||||||
| Europe, Middle East and Africa | 84.7 | 81.5 | 3.9 | % | 160.7 | 158.3 | 1.5 | % | |||||||||||||||||||||||||||
| Asia Pacific | 20.4 | 21.7 | (6.0) | % | 37.1 | 40.3 | (7.9) | % | |||||||||||||||||||||||||||
| Total | $ | 318.6 | $ | 331.0 | (3.7) | % | $ | 608.6 | $ | 642.0 | (5.2) | % | |||||||||||||||||||||||
| Three Months Ended June 30, | Six Months Ended June 30, | ||||||||||||||||||||||
| 2025 | 2024 | 2025 | 2024 | ||||||||||||||||||||
| Weighted Average Outstanding Borrowings | $ | 213.8 | $ | 214.6 | $ | 209.3 | $ | 214.1 | |||||||||||||||
| Average interest rate | 5.67 | % | 6.50 | % | 5.68 | % | 6.33 | % | |||||||||||||||
| Interest expense | 3.0 | 3.5 | 6.2 | 6.8 | |||||||||||||||||||
| Interest income | (0.8) | (1.0) | (1.7) | (1.9) | |||||||||||||||||||
| Interest expense, net | $ | 2.2 | $ | 2.5 | $ | 4.5 | $ | 4.9 | |||||||||||||||
|
For the Quarter Ended
June 30, 2025 |
Total Number of Shares
Purchased
(1)
|
Average Price Paid
Per Share |
Total Number of Shares Purchased as Part of
Publicly Announced Plans or Programs |
Maximum Number of Shares that May Yet Be
Purchased Under the Plans or Programs |
||||||||||
| April 1-30, 2025 | 58,263 | $ | 72.17 | 58,169 | 2,329,026 | |||||||||
| May 1-31, 2025 | 66,413 | $ | 73.78 | 62,582 | 2,266,444 | |||||||||
| June 1-30, 2025 | 59,073 | $ | 75.57 | 59,073 | 2,207,371 | |||||||||
| Total | 183,749 | $ | 73.85 | 179,824 | 2,207,371 | |||||||||
| Item # | Description | Method of Filing | ||||||||||||
| 3.1 | Incorporated by reference to Exhibit 3i to the Company’s report on Form 10-Q for the quarterly period ended June 30, 2006. | |||||||||||||
| 3.2 | Incorporated by reference to Exhibit 3.2 to the Company’s Form 8-K dated January 19, 2023. | |||||||||||||
| 3.3 | Incorporated by reference to Exhibit 3iii to the Company's report on Form 10-Q for the quarterly period ended March 31, 2018. | |||||||||||||
| 31.1 | Filed herewith electronically. | |||||||||||||
| 31.2 | Filed herewith electronically. | |||||||||||||
| 32.1 | Filed herewith electronically. | |||||||||||||
| 32.2 | Filed herewith electronically. | |||||||||||||
| 101 | The following financial information from Tennant Company's Quarterly Report on Form 10-Q for the period ended June 30, 2025, formatted in Inline eXtensible Business Reporting Language (iXBRL): (i) Consolidated Statements of Income for the three and six months ended June 30, 2025 and 2024; (ii) Consolidated Statements of Comprehensive Income for the three and six months ended June 30, 2025 and 2024; (iii) Consolidated Balance Sheets as of June 30, 2025 and December 31, 2024; (iv) Consolidated Statements of Cash Flows for the six months ended June 30, 2025 and 2024; (v) Consolidated Statements of Equity for the six months ended June 30, 2025 and 2024; and (vi) Notes to the Consolidated Financial Statements | Filed herewith electronically. | ||||||||||||
| 104 | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101) | Filed herewith electronically. | ||||||||||||
| TENNANT COMPANY | ||||||||||||||
| Date: | August 7, 2025 | /s/ Fay West | ||||||||||||
|
Fay West
Senior Vice President and Chief Financial Officer (Principal Financial and Accounting Officer)
|
||||||||||||||
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|